AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical ...

Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have earned a consensus recommendation of “Hold” from the twenty-four ...

Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, has selected IBN to manage its corporate communications an ...

Pfizer, Merck & Co., Inc., UnitedHealth Group, Eli Lilly and Company, and AbbVie are the five Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares in ...

Behçet's disease (BD) is a multisystem inflammatory disorder currently classified as a vasculitis. Its etiopathogenesis is unclear, but environmental, genetic and autoimmune factors have been ...

Broader protection induced by combination of COVID adenovirus vaccine plus CiVax TM compared to 2-shot mRNA vaccination series ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update CiVax™ Booster Enhances Protection from COVID-19 in NHPs On March 25, ...

There are key criteria when choosing a location, and Türkiye is rich in term of natural film vistas,’ Turkish Film Commission chair tells Anadolu - Anadolu Ajansı ...